Barclays raises S&P 500 target, Amgen stock slumps after trial failure, and oil prices rise due to escalating Middle East hostilities.

The entities involved

• Barclays →

  British bank

  • QinetiQ carried out share purchases and arranged for a share buyback execution on the London Stock Exchange.Mon 13:19
  • Financial institutions provided ratings on multiple companies on July 8, 2026, including Goldman Sachs reiterating Tesla as neutral, Barclays initiating Toast as overweight, and Bank of America rating Nvidia as a buy.Sun 14:53
• Amgen →

  American multinational biopharmaceutical company

  • Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
  • Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
• Middle East →

  geopolitical region encompassing Egypt and most of Western Asia, including Iran

  • A US Air Force base in Fairford, located near the Oxfordshire border, is being utilized due to actions in the Middle East.Mon 17:54
  • Authorities are investigating an incident at a base in Fairford, with possible links to Iran and Russia.Mon 17:54

Related events

• Ameriprise links energy to inflation damage as AI demand uncertainty affects tech stocks amid Middle East conflict.Sep 15
• Barclays raised S&P 500 price targets, noting that both Meta and Amazon are major Big Tech companies and are expected to contribute significantly to capital expenditures (CapEx).Sep 14
• Tensions in the Middle East are cited as a risk to global markets, influencing S&P 500 trends via tech sector earnings.Jun 10
• The market is reacting to the news of Novartis' drug trial failures, specifically impacting Amgen's stock performance on the Nasdaq exchange.Sep 12
• Tech giants' profits are driving stock prices, but a Middle East crisis poses a risk to the market bubble.Sep 22